TY  - JOUR

T1  - Fracture-related hospitalisations in de novo advanced or metastatic hormone-sensitive prostate cancer: Secondary analysis of the STAMPEDE abiraterone acetate plus prednisone +/- enzalutamide and M1|RT phase 3 trials using health systems data

JO  - European Urology

UR  - https://doi.org/10.1016/s0302-2838(24)01218-1

PY  - 2024/03/01

AU  - Jones C

AU  - Dutey-Magni P

AU  - Murphy L

AU  - Murray M

AU  - Brown J

AU  - Mccloskey E

AU  - Parmar MKB

AU  - Parker C

AU  - Attard G

AU  - James ND

AU  - Sydes MR et al

ED  - 

DO  - DOI: 10.1016/s0302-2838(24)01218-1

PB  - Elsevier BV

VL  - 85

SP  - S1583

EP  - S1583

Y2  - 2025/08/08

ER  -